LOADING
Comparing Johnson & Johnson (JNJ) and Nike Inc (NKE) across the Health Care and Consumer Discretionary sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JNJ | NKE |
|---|---|---|
| Price | $273.63 | $39.70 |
| Change Today | +0.22% | -2.59% |
| Market Cap | $658.0B | $60.5B |
| P/E Ratio | 31.4 | 19.4 |
| Forward P/E | 23.2 | 23.7 |
| PEG Ratio | 4.73 | 1.58 |
| EPS | $8.71 | $2.10 |
| Revenue Growth (YoY) | 6.6% | -1.1% |
| Profit Margin | 21.5% | 6.7% |
| Return on Equity | 25.7% | 22.1% |
| Dividend Yield | 1.94% | 4.05% |
| Beta | 0.23 | 1.12 |
| 52-Week High | $275.11 | $77.37 |
| 52-Week Low | $169.49 | $38.86 |
| Volume | 27K | 821K |
Johnson & Johnson is the larger company by market capitalization. Nike Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Nike Inc offers a higher dividend yield for income investors. Johnson & Johnson has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.